Cite
MLA Citation
Janet E. Pope et al.. “Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open‐Label, Long‐Term Extension Studies up to 9.5 Years.” ACR open rheumatology, vol. 1, no. 2, 2019, pp. 73–82. http://access.bl.uk/ark:/81055/vdc_100081452312.0x000001